Clinical and laboratory characteristics of 144 patients with Mediterranean spotted fever

被引：45

作者：

Antón, E

Font, B

Muñoz, T

Sanfeliu, I

Segura, F

机构：

[1] Corp Parc Tauli, Dept Internal Med, Program Infect Dis, Sabadell 08208, Barcelona, Spain

[2] Corp Parc Tauli, Dept Pediat, Sabadell 08208, Barcelona, Spain

[3] Corp Parc Tauli, Dept Microbiol, Sabadell 08208, Barcelona, Spain

来源：

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 2003年 / 22卷 / 02期

关键词：

D O I：

10.1007/s10096-002-0879-x

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

[No abstract available]

引用

页码：126 / 128

页数：3

共 10 条

[1]

BELLACUETO F, 1987, J INFECT DIS, V155, P1056, DOI 10.1093/infdis/155.5.1056

[2] Efficacy and safety of clarithromycin as treatment for Mediterranean spotted fever in children: A randomized controlled trial [J].

Cascio, A ;

Colomba, C ;

Di Rosa, D ;

Salsa, L ;

di Martino, L ;

Titone, L .

CLINICAL INFECTIOUS DISEASES, 2001, 33 (03) :409-411

[3]

Espejo Arenas E, 1986, LANCET, V1, P1333

[4]

Font Creus B, 1991, Med Clin (Barc), V96, P121

[5]

FONTCREUS B, 1985, REV INFECT DIS, V7, P635

[6] In vitro susceptibilities of Rickettsia and Bartonella spp. to 14-hydroxy-clarithromycin as determined by immunofluorescent antibody analysis of infected Vero cell monolayers [J].

Ives, TJ ;

Marston, EL ;

Regnery, RL ;

Butts, JD ;

Majerus, TC .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (03) :305-310

[7] MEDITERRANEAN SPOTTED-FEVER - CLINICAL, LABORATORY AND EPIDEMIOLOGIC FEATURES OF 199 CASES [J].

RAOULT, D ;

WEILLER, PJ ;

CHAGNON, A ;

CHAUDET, H ;

GALLAIS, H ;

CASANOVA, P .

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1986, 35 (04) :845-850

[8]

RAOULT D, 1983, PRESSE MED, V12, P2375

[9]

SEGURA F, 1982, LANCET, V2, P280

[10] Mortality in serologically unconfirmed Mediterranean spotted fever [J].

Yagupsky, P .

JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (02) :809-810

← 1 →